Marie Bill

发表

Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.

E. Kjeldsen, P. Hokland, A. T. Simonsen, 2020, Leukemia research.

Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients

B. Honoré, H. Hasle, O. Rahbek, 2022, Cancers.

OMIP 072: A 15‐color panel for immunophenotypic identification, quantification, and characterization of leukemic stem cells in children with acute myeloid leukemia

Marie Bill, Marianne A Petersen, C. Rosenberg, 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A‐related cancer stem cell biology

P. Hokland, L. Nederby, Marie Bill, 2018, Journal of cellular and molecular medicine.

Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry

E. Kjeldsen, O. Maguire, P. Hokland, 2021, Cytometry. Part B, Clinical cytometry.

Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine‐learning assisted morphometrics

P. Hokland, G. Kerndrup, M. Ludvigsen, 2020, Cytometry. Part B, Clinical cytometry.

Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL‐2 expression by cytogenetic subgroups

E. Kjeldsen, R. Brøndum, H. Hasle, 2022, British journal of haematology.

The concept of leukaemic stem cells in acute myeloid leukaemia 25 years on: hitting a moving target

P. Woll, P. Hokland, Marie Bill, 2019, British journal of haematology.

Revisiting CLEC12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy

E. Kjeldsen, P. Hokland, A. Aggerholm, 2018, British journal of haematology.

Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation

A. Aggerholm, J. Soerensen, A. Roug, 2022, Bone Marrow Transplantation.

Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.

P. Hokland, A. Aggerholm, J. Soerensen, 2020, Blood advances.

Refining remission evaluation in MDS with isolated del(5q)

E. Kjeldsen, Marie Bill, 2018, British journal of haematology.

Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo

M. Nyegaard, R. Bak, Zongliang Gao, 2023, Leukemia.

Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia

Marie Bill, C. Rosenberg, Trine Engelbrecht Hybel, 2024, International journal of molecular sciences.

A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo

A. Bentzen, T. Yoshizato, M. Griffioen, 2023, Nature Cancer.